Daily Health Headlines

Are Birth Control Pills Tied to Decline in Ovarian Cancer Deaths?

👤by Robert Preidt 0 comments 🕔Wednesday, September 7th, 2016

WEDNESDAY, Sept. 7, 2016 (HealthDay News) -- Ovarian cancer deaths are down dramatically in many parts of the world, and researchers believe the use of birth control pills may be a main reason why.

The analysis of World Health Organization data found that the ovarian cancer death rate fell 16 percent in the United States and almost 8 percent in Canada between 2002 and 2012.

In the European Union, the ovarian cancer death rate fell 10 percent, though some countries saw far more significant drops. The United Kingdom's ovarian cancer death rate went down by 22 percent. Denmark and Sweden each saw a drop of 24 percent in their death rate from ovarian cancer, the researchers said.

Ovarian cancer deaths also decreased about 12 percent in both Australia and New Zealand. In Japan, the ovarian cancer death rate declined 2 percent, the study found. Japan has low rates of birth control use, the researchers said.

Ovarian cancer death rates are expected to continue to decline 15 percent in the United States, and 10 percent in the European Union and Japan by 2020.

In Latin America, the results were mixed. Argentina, Chile and Uruguay had decreases in ovarian cancer death rates between 2002 and 2012. But, Brazil, Colombia, Cuba, Mexico and Venezuela all had increases, according to the study.

The study was published Sept. 6 in the journal Annals of Oncology.

The study wasn't designed to prove cause-and-effect. However, a big reason for the decline in ovarian cancer death rates in some parts of the world is likely the use of birth control pills and the long-term protection against ovarian cancer they provide, study leader Dr. Carlo La Vecchia, a professor in the Faculty of Medicine at the University of Milan, Italy, and colleagues, suggested.

Other factors may include reduced use of hormone replacement therapy to manage menopausal symptoms and better diagnosis and treatment of ovarian cancer, the researchers said.

"As our understanding of preventable causes of this major cancer progresses, early detection strategies are being developed and novel therapeutic options become available, we enhance our ability to reduce ovarian cancer mortality," Dr. Paolo Boffetta, the journal's associate editor, wrote in an accompanying editorial. Boffetta is also director of the Institute of Translational Epidemiology at the Icahn School of Medicine at Mount Sinai in New York City.

-- Robert Preidt

Article Credits / Source

Robert Preidt / HealthDay

Robert Preidt wrote this story for HealthDay. HealthDay provides up to the minute breaking health news. Click here to view this full article from HealthDay.

SOURCE: Annals of Oncology, news release, Sept. 6, 2016

View More Articles From Robert Preidt 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More Cancer Articles

No Benefit From Routine Thyroid Cancer Screening: Task Force

No Benefit From Routine Thyroid Cancer Screening: Task Force0

TUESDAY, Nov. 22, 2016 (HealthDay News) -- Doctors should not screen for thyroid cancer in patients who have no symptoms of the disease, according to a U.S. Preventive Services Task Force draft recommendation. It reaffirms a recommendation ...

Depressed Women Less Likely to Get Best Breast Cancer Care: Study

Depressed Women Less Likely to Get Best Breast Cancer Care: Study0

FRIDAY, Nov. 18, 2016 (HealthDay News) -- Breast cancer patients with a history of depression are less likely to receive recommended care for their disease, a new study finds. The study included more than 45,000 Danish women diagnosed with ...

Earnings Fall After a Child's Cancer Diagnosis

Earnings Fall After a Child's Cancer Diagnosis0

MONDAY, Nov. 21, 2016 (HealthDay News) -- After a child's cancer diagnosis, parents' income often drops and mothers frequently stop working, a new study finds. Moreover, the financial effects of a cancer diagnosis can last years, with mothers' ...

Monoclonal Antibodies

Monoclonal Antibodies0

home / cancer center / cancer a-z list / monoclonal antibodies index / monoclonal antibodies drug monograph Pharmacy Author: Omudhome Ogbru, PharmD Omudhome Ogbru, PharmDDr. Ogbru received his ...

New Drug May Brighten Outlook for Advanced Breast Cancer

New Drug May Brighten Outlook for Advanced Breast Cancer0

WEDNESDAY, Nov. 16, 2016 (HealthDay News) -- A recently approved drug can help slow the progression of advanced breast cancer, a new clinical trial confirms. The drug, called palbociclib (Ibrance), was approved in the United States last year ...

View More Cancer Articles


Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!